Instituto Nacional de Pesquisas da Amazônia, Caixa Postal 2223-CEP 69080-971, Manaus, Amazonas, Brasil.
Molecules. 2013 May 29;18(6):6281-97. doi: 10.3390/molecules18066281.
A new indole alkaloid, 12-hydroxy-N-acetyl-21(N)-dehydroplumeran-18-oic acid (13), and 11 known indole alkaloids: 3,4,5,6-tetradehydro-β-yohimbine (3), 19(E)-hunteracine (4), β-yohimbine (5), yohimbine (6), 19,20-dehydro-17-α-yohimbine (7), uleine (10), 20-epi-dasycarpidone (11), olivacine (8), 20-epi-N-nor-dasycarpidone (14), N-demethyluleine (15) and 20(E)-nor-subincanadine E (12) and a boonein δ-lactone 9, ursolic acid (1) and 1D,1O-methyl-chiro-inositol (2) were isolated from the EtOH extracts of different parts of Aspidosperma ulei Markgr. (Apocynaceae). Identification and structural elucidation were based on IR, MS, ¹H- and ¹³C-NMR spectral data and comparison to literature data. The antiplasmodial and antimalarial activity of 1, 5, 6, 8, 10 and 15 has been previously evaluated and 1 and 10 have important in vitro and in vivo antimalarial properties according to patent and/or scientific literature. With the aim of discovering new antiplasmodial indole alkaloids, 3, 4, 11, 12 and 13 were evaluated for in vitro inhibition against the multi-drug resistant K1 strain of the human malaria parasite Plasmodium falciparum. IC₅₀ values of 14.0 (39.9), 4.5 (16.7) and 14.5 (54.3) mg/mL (mM) were determined for 3, 11 and 12, respectively. Inhibitory activity of 3, 4, 11, 12 and 13 was evaluated against NIH3T3 murine fibroblasts. None of these compounds exhibited toxicity to fibroblasts (IC₅₀ > 50 mg/mL). Of the five compounds screened for in vitro antiplasmodial activity, only 11 was active.
从 Aspidosperma ulei Markgr.(夹竹桃科)不同部位的乙醇提取物中分离得到 13 种新的吲哚生物碱:12-羟基-N-乙酰-21(N)-去氢普卢默烷-18-酸(13)和 11 种已知的吲哚生物碱:3,4,5,6-四氢-β-育亨宾(3)、19(E)-亨特碱(4)、β-育亨宾(5)、育亨宾(6)、19,20-去氢-17-α-育亨宾(7)、乌利卡因(10)、20-表-达西卡酮(11)、奥立瓦辛(8)、20-表-N-去甲达西卡酮(14)、N-去甲基乌利卡因(15)和 20(E)-去亚-N-辛可宁碱 E(12)和一种波尼因 δ-内酯 9、熊果酸(1)和 1D,1O-甲基-手性肌醇(2)。鉴定和结构解析基于 IR、MS、1H 和 13C-NMR 光谱数据,并与文献数据进行比较。1、5、6、8、10 和 15 的抗疟原虫和抗疟活性以前已经进行了评估,根据专利和/或科学文献,1 和 10 具有重要的体外和体内抗疟特性。为了发现新的抗疟原虫吲哚生物碱,评估了 3、4、11、12 和 13 对人类疟原虫 Plasmodium falciparum 多药耐药 K1 株的体外抑制作用。确定了 3、11 和 12 的 IC₅₀ 值分别为 14.0(39.9)、4.5(16.7)和 14.5(54.3)mg/mL(mM)。还评估了 3、4、11、12 和 13 对 NIH3T3 鼠成纤维细胞的抑制活性。这些化合物均未显示对成纤维细胞的毒性(IC₅₀ > 50 mg/mL)。在筛选的五种具有体外抗疟活性的化合物中,只有 11 种具有活性。